Lipson et al. showed that an endogenous immune response promotes PD-L1 expression in the MCC microenvironment and provides a rationale for investigating therapies blocking PD-1/PD-L1 for patients with MCC, and could be related to overall survival [45]. The gene discussed is CD274; the disease is Merkel cell skin cancer.